A Randomised Trial of a Weight Loss Intervention for Overweight and Obese People Diagnosed with Coronary Heart Disease And/or Type 2 Diabetes
Overview
Authors
Affiliations
Background: Weight reduction limits disease progression in obese people with coronary heart disease (CHD) and/or type 2 diabetes mellitus (T2DM).
Purpose: To test a 16-week group-based weight reduction intervention combining exercise, diet and behaviour change strategies aimed to increase self-efficacy (Healthy Eating and Exercise Lifestyle Program-HEELP) on weight, body mass index (BMI), waist circumference and exercise.
Methods: Participants with CHD and/or T2DM and BMI between 27 to 39 kg/m(2) were randomised to HEELP (n=83) or usual care (n=65).
Results: Participants were aged a mean 63.47 years (SD 8.9), male (58 %) and Caucasian (79 %). HEELP participants lost significantly more weight, BMI and waist circumference and exercised more days/week for a longer duration/week than usual care. Clinically significant weight loss (≥5 %) was more common in HEELP than usual care.
Conclusion: The HEELP resulted in weight loss and improved exercise behaviour in obese people with CHD and T2DM.
Maudet-Coulomb E, Martin-Krumm C, Tarquinio C, Mino J Health Sci Rep. 2024; 7(3):e1644.
PMID: 38469114 PMC: 10925881. DOI: 10.1002/hsr2.1644.
Respiratory health effects of e-cigarette substitution for tobacco cigarettes: a systematic review.
Qureshi M, Vernooij R, La Rosa G, Polosa R, OLeary R Harm Reduct J. 2023; 20(1):143.
PMID: 37794458 PMC: 10552385. DOI: 10.1186/s12954-023-00877-9.
Massar R, McMacken M, Kwok L, Joshi S, Shah S, Boas R Nutrients. 2023; 15(13).
PMID: 37447186 PMC: 10343841. DOI: 10.3390/nu15132857.
Sandhu S, Angel C, Campbell K, Hickman I, MacLaughlin H Nutrients. 2021; 13(10).
PMID: 34684389 PMC: 8538850. DOI: 10.3390/nu13103388.
Ferguson C, Inglis S, Gallagher R, Davidson P Heart Lung Circ. 2020; 29(12):1744-1748.
PMID: 33067125 PMC: 7553902. DOI: 10.1016/j.hlc.2020.09.921.